.Merck beats earnings assumptions, increases sales expectation on solid need for top medicines like Keytruda CNBCMerck & Co. (MRK US) Beats Income Estimates as Keytruda Purchases Increase BloombergMerck Stock: Pharma Titan Posts Strong End Results, However Outlook Falls Short Client's Organization DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck defeats profit and also purchases expectations amidst Keytruda advantage, but supplies combined full-year expectation MarketWatch.